Akari Therapeutics Plc (AKTX)

8.58 +0.36 (+4.32%) USD  |  NASDAQ  |  Oct 26, 13:18
More

Akari Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Bicycle Therapeutics Plc Upgrade
argenx SE --
Autolus Therapeutics Plc Upgrade